Videos
Onera Health Video
Quotes
David White, M.D., Ph.D., Professor of Medicine at Harvard Medical School, Member Medical Advisory Board Onera Health
“Onera Health has created an innovative solution that satisfies the needs of both sleep doctors and their patients. Sleep experts require a comprehensive understanding of a patient's sleep beyond just respiratory data. However, patients usually prefer conducting their sleep study at home instead of in a sleep lab. Onera's solution effectively resolves both of these issues. It provides sleep doctors with clinical-grade PSG data, while its sleek and user-friendly device makes it easy for patients to conduct a sleep study without supervision. This kind of solution makes sleep testing much more efficient and accessible, which is especially beneficial in a field where patients often remain undiagnosed for far too long.”
Bruce C. Cozadd, Chairman and Chief Executive Officer at Jazz Pharmaceuticals
“As a leader in sleep medicine, Jazz Pharmaceuticals is excited about its investment in Onera’s breakthrough sleep technology and continuing our focus in innovation in this therapeutic area.”
Jed Black, M.D., SVP, senior fellow, neuroscience at Jazz Pharmaceuticals and adjunct professor, Stanford University Medical Center, Stanford Center for Sleep Sciences and Medicine
“We believe the solutions Onera Health are developing could transform diagnostic and treatment-monitoring processes in sleep medicine. Onera’s hardware and software innovations, as well as its streamlined service model, have the potential to empower clinicians to provide patients with optimal sleep care.”
Hartmut Schneider, M.D., Ph.D., Founder & Chief Medical Officer at Onera Health, and Associate Professor at Johns Hopkins University
“Being a leader in sleep research, I’ve always strived to teach sleep specialists and primary care physicians alike, passing on the knowledge, skills and insights necessary to diagnose and treat sleep disorders. Onera’s innovations are like finding the missing piece to a puzzle; the medical field finally has the tools they need to offer comprehensive sleep care.”
Tom Vanhoutte, Partner at imec.expand and Board Member of Onera Health
“Imec.xpand invests in companies that have the potential to become global players by disrupting their entire industry. We’re convinced that the Onera team, and their close cooperation with imec, has the skills, business acumen and vision to set the new gold standard in sleep diagnostics.”
Luc Van den hove, President and Chief Executive Officer at imec
“Imec is proud of the progress made by Onera. It’s inspiring to see another imec spin-off having great success in creating breakthrough medical technologies. Onera is capitalizing on its new funding to revolutionize the field of sleep studies, adhering to imec's core focus of innovation in nanoelectronics and digital technologies.”
Ruben de Francisco, Founder & CEO at Onera Health
“Our mission is to help the medical field provide the much-needed answers for millions who are affected by sleep disorders. For far too long, people avoided searching for those answers because understanding their issues was expensive, inconvenient, or unreliable. And nobody enjoys spending hours hooked up to sensors in a sleep lab. Our patch-based sensor system, in combination with our Onera Digital Health Platform, empowers sleep professionals with powerful solutions that provide scalable, patient-friendly diagnostics and treatment monitoring – accessible anytime and anywhere.”
Investors
EQT Life Sciences
EQT Life Sciences was formed in 2022 following the integration of LSP, a leading European life sciences venture capital firm, into the EQT platform. As LSP, the firm raised over EUR 3.0 billion and supported the growth of more than 150 companies since it started to invest over 30 years ago. With a dedicated team of highly experienced investment professionals coming from backgrounds in medicine, science, business, and finance, EQT Life Sciences backs the smartest inventors who have ideas that could truly make a difference for patients. The team combines deep sector knowledge, analytical skills, and investment experience to provide the added value that inventors seek. For more information, please visit https://eqtgroup.com/private-capital/life-sciences/
imec.xpand
imec.xpand is an early-stage and growth venture capital fund with powerful strategies that evolve hardware-driven nanotechnology innovations into successful global companies. The fund is independently managed by a team of entrepreneurs, seasoned investors and business experts who target ambitious tech start-ups where imec technology, expertise and infrastructure can impact success. For more information, please visit www.imecxpand.com
Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc (Nasdaq: JAZZ), a global biopharmaceutical company, is dedicated to developing life-changing medicines for people who have limited or no options. As a leader in sleep medicine and with a growing hematology/oncology portfolio, Jazz has a diverse portfolio of products and product candidates in development, and is focused on transforming biopharmaceutical discoveries into novel medicines. For more information, please visit www.jazzpharmaceuticals.com
Invest-NL
Invest-NL is an impact investor committed to businesses and projects that will make the Netherlands more sustainable and innovative. Its focus lies on carbon-neutral and circular economy and on innovative, fast-growing companies, or scale-ups. Invest-NL supports innovative entrepreneurs through financing and advice according to one simple principle: impact is our goal, return is our means. As the Dutch partner for European investment institutions, Invest-NL is dedicated to cooperation and always works together with other investors. Invest-NL is headquartered in Amsterdam and employs a staff of 60 people. For more information, go to www.invest-nl.nl
Gimv
Gimv is a European investment company, listed on Euronext Brussels and part of the Euronext BEL ESG Index. As a recognised market leader in selected investment platforms, Gimv identifies entrepreneurial, innovative companies with high growth potential and supports them in their transformation into market leaders. Gimv's five investment platforms are Consumer, Healthcare, Life Sciences, Smart Industries, and Sustainable Cities. In Life Sciences, Gimv focuses on European R&D-focused companies developing breakthrough solutions that have a positive impact on human health, from early preclinical proof of concept through to late-stage clinical trials. For more information, please visit www.gimv.com
Innovation Industries
Innovation Industries is a Deeptech venture capital investor that invests up to €30M in Hightech, Agri&Foodtech and Medtech businesses.Today, Innovation Industries manages over €275M across two funds and has a team of 15 investment professionals. Its largest investors are the Dutch pension funds PME and PMT. Innovation Industries invests from seed to late stage and has partnerships with all Dutch technical universities and research institute TNO. For more information on Innovation Industries see: www.innovationindustries.com
BOM
BOM (the Brabant Development Agency) works with businesses to ensure the Netherlands province of Brabant thrives economically, enjoys employment growth, maintains a high quality of life and plays a leading role on the world stage. They share insights and experience, foster partnerships, create networks and provide investment capital to innovative local companies and sustainable energy projects. They encourage foreign companies to settle in Brabant, while local businesses are assisted to extend their reach abroad. Through Brabant Ventures, BOM helps fund and support ambitious local startups and scaleups in high-tech systems and software, agri-food, life sciences & health, supply chain, and the bio-based economy. For more information, please visit www.bom.nl/brabant-ventures
15th Rock
15th Rock is a venture capital firm that invests in human augmentation and consumer services. Human augmentation is a technology that expands human capabilities through the power of technology, making it possible to learn a variety of skills that were previously impossible and extend healthy life expectancy. Through our investment in this field, we aim to create new lifestyles and new norms that transcend preconceived notions, age, and all barriers. For more information, please visit www.en.15th-rock.com
